Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Jul 2;5(7):e006733. doi: 10.1136/bmjopen-2014-006733

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/

PMC Copyright notice

Cost-effectiveness results. (A) Cost-Effectiveness Acceptability Curve (CEAC): ER versus Placebo/SC for rash subgroup. Note: Vertical reference lines are CE threshold values of £50 000 and the observed cost/QALY (£56 770). The horizontal reference line is 0.8. (B) Cost-Effectiveness Plane: ER versus Placebo/SC (rash subgroup). Note: The first vertical reference line is 0. The horizontal and second vertical reference lines are observed incremental effect (0.139) and observed incremental cost (£7891), respectively.